Daily non-political popular news in brief.

Researchers begin randomized double-blind trial of airway bypass treatment for emphysema

05-17-2007 · EurekAlert!

Broncus Technologies Inc., today announced the start of its EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational procedure that may offer a new, minimally-invasive treatment option for millions of emphysema sufferers. The study focuses on a procedure called airway bypass that uses drug-eluting stents to reinforce new pathways in the lung for trapped air to escape. This in turn, may relieve severe emphysema symptoms such as shortness of breath.

Keywords: researchers, begin, randomized, double-blind, trial, airway, bypass, treatment, emphysema, researcher, double, blind

« Previous | Next »

Similar news on "Researchers begin randomized double-blind trial of airway bypass treatment for emphysema":

Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema
02-11-2008 · EurekAlert!
Researchers at Pulmonary Associates today announced the start of the EASE Trial, a multicenter clinical trial to explore Airway Bypass, an investigational treatment that may offer a new, minimally invasive option for those suffering with advanced widespread emphysema.
Similar news · Read more »
Researchers at Cedars-Sinai Medical Center to study airway bypass treatment for emphysema
06-06-2007 · EurekAlert!
Researchers at Cedars-Sinai Medical Center announced today the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally-invasive option for those suffering with advanced widespread emphysema.
Similar news · Read more »
Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
12-17-2007 · EurekAlert!
Researchers at Sarasota Memorial Health Care System today announced the start of the EASE trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new, minimally-invasive option for those suffering with advanced widespread emphysema. The study focuses on a procedure called airway bypass that involves creating pathways in the lung for trapped air to escape and in turn, relieve emphysema symptoms including shortness of breath.
Similar news · Read more »
Researchers at Peoria Pulmonary Associates to study airway bypass procedure for emphysema
01-28-2008 · EurekAlert!
Researchers at Peoria Pulmonary Associates today announced the start of the EASE Trial, an international, multi-center clinical trial to explore an investigational procedure for advanced widespread emphysema/COPD. Conducted at Methodist Medical Center, the study focuses on a procedure called airway bypass. Airway bypass is a bronchoscopic procedure designed to reduce lung hyperinflation and shortness of breath (the clinical hallmarks of emphysema/COPD) by making new pathways for trapped air to exit the lungs.
Similar news · Read more »
Catalyst Pharmaceutical Partners, Inc. Initiates U.S. Phase II Clinical Trial of CPP-109 in Patients With Cocaine Dependence
07-10-2007 · Brookhaven National Laboratory
Catalyst Pharmaceutical Partners, Inc., a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence. CPP-109, an orally administered, small molecule drug which inhibits psychostimulant-induced dopamine release, is Catalyst's lead compound, vig
Similar news · Read more »
Researchers at Penn study new airway bypass treatment to help emphysema sufferers breathe easier
04-04-2007 · EurekAlert!
Researchers at the University of Pennsylvania School of Medicine are now studying an investigational treatment that may offer a significant new, minimally-invasive option for those suffering from advanced widespread emphysema.
Similar news · Read more »
New York Methodist Hospital to study airway bypass treatment for emphysema
02-04-2008 · EurekAlert!
New York Methodist Hospital today announced the start of the EASE Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new, minimally-invasive option for those suffering with advanced widespread emphysema. The study focuses on a procedure called airway bypass that involves creating pathways in the lung for trapped air to escape and in turn, relieve emphysema symptoms including shortness of breath.
Similar news · Read more »
Involving parents in therapy doubles success rates for bulimia treatment
09-03-2007 · EurekAlert!
In the first randomized controlled trial for adolescent bulimia nervosa to be completed in the US, researchers show that mobilizing parents to help an adolescent overcome the disorder can double the percentage of teens who were able to abstain from binge eating and purging after six months.
Similar news · Read more »
Black cohosh does not relieve menopausal hot flashes, Group Health researchers find
12-18-2006 · EurekAlert!
The herbal supplement black cohosh does not relieve hot flashes among women going through menopause. In this double-blinded randomized controlled trial of 351 women, researchers found no significant difference between the numbers of hot flashes in women taking various forms of black cohosh compared to women taking a placebo. Hormone therapy, on the other hand, significantly reduced the frequency of hot flashes.
Similar news · Read more »
Study: Antibiotic gives hope to patients with IBS
10-16-2006 · EurekAlert!
A new study found that patients reported greater global improvements in irritable bowel syndrome symptoms and less bloating after taking rifaximin than patients taking placebo. The randomized, double-blind study is the first to demonstrate a sustained benefit of an antibiotic for IBS symptoms after treatment is stopped.
Similar news · Read more »